Clarity Pharmaceuticals Ltd (CLRPF)
OTCMKTS · Delayed Price · Currency is USD
2.120
0.00 (0.00%)
Sep 5, 2025, 9:30 AM EDT
Clarity Pharmaceuticals Revenue
In the fiscal year ending June 30, 2025, Clarity Pharmaceuticals had annual revenue of 9.46M AUD, down -17.76%. Clarity Pharmaceuticals had revenue of 4.77M in the half year ending June 30, 2025, with 17.37% growth.
Revenue
9.46M AUD
Revenue Growth
-17.76%
P/S Ratio
124.42
Revenue / Employee
137.14K AUD
Employees
69
Market Cap
771.90M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 9.46M | -2.04M | -17.76% |
| Jun 30, 2024 | 11.51M | 1.71M | 17.41% |
| Jun 30, 2023 | 9.80M | 3.34M | 51.74% |
| Jun 30, 2022 | 6.46M | 3.26M | 102.06% |
| Jun 30, 2021 | 3.20M | 407.65K | 14.62% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Longduoduo Company | 4.99M |